Catalin Mihalcioiu

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Miles C. Andrews, Connie P.M. Duong, Vancheswaran Gopalakrishnan et al. · Nature Medicine · 2021 · 415 citations · Full text

Life Sciences, Immunology, Oncology +17

Survival Outcomes in Patients With Previously Untreated <i>BRAF</i> Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

Paolo A. Ascierto, Georgina V. Long, Caroline Robert et al. · JAMA Oncology · 2018 · 345 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · Journal of Clinical Oncology · 2020 · 227 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population

Alain Demers, Zoann Nugent, Catalin Mihalcioiu et al. · Journal of the American Academy of Dermatology · 2005 · 150 citations

Medicine, Dermatology, Oncology +14